Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/417,899 Related to Combination Product of Vascepa® and Statin Therapy
5/22/2013
More...
|
New Japanese Protozoal Patent for BioDiem Ltd. (BDM.AX)'s BDM-I
5/22/2013
More...
|
European and U.S. Cellulase Patents Granted to DIREVO Industrial Biotechnology GmbH
5/21/2013
More...
|
Acorda Therapeutics (ACOR) Announces Issuance of Additional U.S. Patent for AMPYRA® Covering a Range of Dosage Strengths
5/20/2013
More...
|
NeoStem, Inc. Announces Geographic Expansion of Intellectual Property Coverage of Cardiovascular Asset AMR-001
5/16/2013
More...
|
MultiCell Technologies Inc. (MCET.OB) Files U.S. Patent Application for Targeted Delivery of Noncoding Micro RNAs for the Treatment of Liver Cancer
5/16/2013
More...
|
Cellectis: TAL-effector Nuclease: Issuance by the USPTO of Two New Patents
5/16/2013
More...
|
Multi-Party and Cross-Border Patent Issues Affecting Biotech Businesses
5/16/2013
More...
|
Nuvo Research Inc. (NRI.TO) Granted U.S. Patent for Treatment of Allergic Rhinitis and Allergic Asthma With WF10
5/15/2013
More...
|
Cleveland Biolabs Inc. (CBLI) and Incuron Announce US and European Patent Allowances for Curaxins
5/14/2013
More...
|
Aegis Therapeutics, LLC Awarded 2nd Patent for Fast Acting Migraine Nasal Spray Treatment
5/14/2013
More...
|
Trius Therapeutics (TSRX) Announces Notice of Allowance of U.S. Patent Application Related to Tedizolid Phosphate Combination With Daptomycin
5/13/2013
More...
|
Actinium Pharmaceuticals, Inc. Receives Notice of Patent Allowance for a Key Application
5/13/2013
More...
|
Biotage AB (BIOTa.ST) and Peptide Synthesis
5/13/2013
More...
|
NuPathe Inc. (PATH) Announces Allowance of Additional U.S. Patent Application for NP201
5/13/2013
More...
|
Suven Life Sciences Ltd Secures Three Product Patents for Their NCEs in Canada and Eurasia
5/10/2013
More...
|
Nuvo Research Inc. (NRI.TO) Announces Notice of Intention to Grant a European Patent for PENNSAID® 2%
5/9/2013
More...
|
CEM Corporation Wins Peptide Patent Dispute With Biotage AB (BIOTa.ST)
5/9/2013
More...
|
Immunomedics, Inc. (IMMU) Announces Three New Patent Awards
5/7/2013
More...
|
Provitro Biosciences Awarded First-Ever U.S. Patent for Large-Scale Production of Bamboo Plants
5/7/2013
More...
|
Arrowhead Research Corporation (ARWR) Receives Patent Allowance for DPC siRNA Delivery System With Peptide Backbone
5/7/2013
More...
|
Patent Issued in China for EntreMed, Inc. (ENMD)'s Lead Drug Candidate ENMD-2076
5/6/2013
More...
|
Mapi Pharma Granted United States Patent Covering Glatiramer Depot for Multiple Sclerosis
5/6/2013
More...
|
Novartis AG (NVS) Sees Boost From Program Designed to Speed Life-Saving Therapies
5/6/2013
More...
|
GE Global Research Researcher Receives 200th U.S. Patent
5/6/2013
More...
|
Patent Issued in U.S. for EntreMed, Inc. (ENMD)'s 2ME2 in Rheumatoid Diseases
5/3/2013
More...
|
Palatin Technologies (PTN) Announces Notification of Patent Allowance on Melanocortin Receptor-Specific Peptides for Sexual Dysfunction
5/2/2013
More...
|
mPhase Technologies, Inc. (XDSL) Receives Issue Notification of Key Patent
5/2/2013
More...
|
Microbix Biosystems Inc. (MBXBF) to Receive New LumiSort® Patent in U.S.
5/1/2013
More...
|
USPTO Notice of Allowance Marks Major Achievement for Protelica's Series of VEGFR-2 Antibody Mimics
5/1/2013
More...
|
Imugene Limited (IMU.AX) Granted Chinese Patent for Novel Drug Delivery Technology
4/30/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Welcomes Landmark "Victory for Patient" in Intellectual Property Case
4/30/2013
More...
|
Catabasis Pharmaceuticals, Inc. Announces Issuance of Patents for CAT-1000 and CAT-2000 Series
4/30/2013
More...
|
Absorption Pharmaceuticals to Receive Patent for Premature Ejaculation Topical Medication
4/29/2013
More...
|
Islet Sciences Receives Japanese Patent Covering New Medications for Diabetes
4/29/2013
More...
|
NuPathe Inc. (PATH) Announces Allowance of U.S. Patent Application for NP201
4/25/2013
More...
|
Elite Pharmaceuticals, Inc. (ELI) Awarded Second U.S. Patent for Abuse Resistant Drug Formulation
4/23/2013
More...
|
Innovus Pharma Announces Allowance of Patent in Europe for Its J. Regia Product
4/23/2013
More...
|
GW Pharmaceuticals Announces U.S. Patent Allowance for SATIVEX® Formulation Spray Device
4/22/2013
More...
|
ARTES Biotechnology Issued New Patent in Australia for VLP Technology
4/22/2013
More...
|
Fuisz Pharma Announces Intent to Divest Strategic Patent for Detection of Opioid Abuse; Seeks Offers for Patent Through May 2013
4/22/2013
More...
|
Addex Therapeutics (ADXN.SW) Announces Issuance of a Broad European Composition of Matter Patent for Dipraglurant
4/22/2013
More...
|
Medgenics, Inc. Receives Notice of Allowance From the U.S. Patent Office for Claims That Expand IP for Its Platform Technology to Additional Therapeutic Proteins
4/22/2013
More...
|
Adamas Pharmaceuticals Announces Issuance of First U.S. Patent for Nurelin™ (Amantadine HCl Extended Release) Program
4/22/2013
More...
|
Santaris Pharma A/S Release: EPO Appeal Board Decides in Favor of the Wengel LNA Patent
4/18/2013
More...
|
Starpharma Holdings Ltd Granted New Drug Delivery Patents
4/17/2013
More...
|
Suven Life Sciences Ltd Secures 4 Product Patents for Their NCEs in China, Mexico and New Zealand
4/17/2013
More...
|
Prima Biomed (PRR.AX) Awarded Japanese Patent for CVac™
4/17/2013
More...
|
Celsus Therapeutics Announces Notification of Patents Granted
4/17/2013
More...
|
Mayo Clinic Issued Patent Covering Personalized Psychiatric Medicine Technology Commercialized by AssureRx
4/16/2013
More...
|
Antares Pharma, Inc. (AIS) Announces the Issuance of a New Patent on VIBEX™ Device Platform
4/16/2013
More...
|
Veritas Bio's RNA Delivery Patent Allowed by USPTO
4/16/2013
More...
|
Glenmark Pharmaceuticals to Respond to Patent Row With Merck & Co., Inc. (MRK) Next Month
4/15/2013
More...
|
Repros Therapeutics Inc. (RPRX) Reports Issuance of Two Additional U.S. Androxal® Patents
4/10/2013
More...
|
Nodality, Inc. Announces Expansion of Company's Patent Estate Covering Programs to Improve the Treatment of Patients With Severe Diseases in Immunology, Oncology, and Autoimmune Diseases
4/10/2013
More...
|
PROLOR Biotech (PBTH) Receives Notice of Allowance For New U.S. Patent Covering Long-Acting Coagulation Factors VII and IX
4/8/2013
More...
|
Acura Pharmaceuticals, Inc. (ACUR) Awarded U.S. Patent for Abuse Deterrent Drug Formulations
4/5/2013
More...
|
Santaris Pharma A/S Release: USPTO Issues Inter Partes Reexamination Certificate of Key LNA Patent
4/5/2013
More...
|
Antares Pharma, Inc. (AIS) Announces Notice of Allowance for New Patent on VIBEX™ QuickShot Device
4/5/2013
More...
|
NeuralStem Inc. Receives Notice of Allowance of Patent Covering Use of Stem Cells to Treat Amyotrophic Lateral Sclerosis
4/5/2013
More...
|
VolitionRX Files Two Patent Applications
4/4/2013
More...
|
Synthetic Biologics, Inc. (AEN) Announces Issuance of U.S. Patent Covering Combination of Estriol and Copaxone® for Multiple Sclerosis
4/4/2013
More...
|
22nd Century Group, Inc. Announces U.S. Patent Issues for MPO Nicotine Biosynthesis Gene
4/3/2013
More...
|
Islet Sciences Receives Notice of Claims Allowance for U.S. Patent Application for New Medications for Treating Diabetes and other Serious Inflammatory Disorders
4/3/2013
More...
|
Oramed Pharmaceuticals Inc. (ORMP.OB) Granted Japanese Patent for Its Core Technology in Oral Delivery of Proteins
4/3/2013
More...
|
KemPharm, Inc. Receives Notice of Allowance for Novel Pain Drug Candidate, KP201
4/3/2013
More...
|
Zalicus Inc. (ZLCS) Granted Key Formulation Patent for Z160
4/2/2013
More...
|
Entia Biosciences Receives Notices of Allowance for Its Ergothioneine and Genetic Transporter Patents from the United States, Canada, and Israel
4/2/2013
More...
|
Lithera Receives Patent From the USPTO Protecting Methods of Use and Formulations for LIPO-202
4/2/2013
More...
|
AstraZeneca PLC (AZN) Suffers Fresh Drug Patent Setback in U.S.
4/2/2013
More...
|
Novartis AG (NVS) Loses Cancer Drug Glivec Patent Case
4/1/2013
More...
|
Cytori Therapeutics, Inc. (CYTX) Patents Method of Treating Renal Diseases Using Adipose-Derived Regenerative Cells
3/28/2013
More...
|
Nutra Pharma Corp. (NPHC) Patent and Trademarks Published in India
3/25/2013
More...
|
Lpath, Inc. Granted Key European and U.S. Patents Related to Anti-Cancer Drug Program, ASONEP
3/22/2013
More...
|
Epizyme Granted First Patent Covering Personalized Therapeutic Drug Candidate E7438
3/22/2013
More...
|
European Patent Office to Grant Patent for Macrocure's CureXcell®
3/21/2013
More...
|
StemCells Inc. (STEM) Expands Patent Portfolio
3/20/2013
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: U.S. Patent Office Grants Patent Claiming Dosing Regimen for TECFIDERA™ (Dimethyl Fumarate)
3/20/2013
More...
|
Palatin Technologies (PTN) Announces Notification of Patent Allowance on Melanocortin Receptor-1 Specific Peptides
3/19/2013
More...
|
Dicerna Pharmaceuticals Announces Patent Issuance for DsiRNAs Directed at the KRAS Gene, a Key Cancer Regulator
3/19/2013
More...
|
St. Jude Children's Research Hospital Announces Issuance of U.S. Patent for Genetically Modified Human Immune Cells for Cancer Therapy
3/19/2013
More...
|
Cereplast Files Patent on Algae Bio-Content Polymers
3/19/2013
More...
|
Northwest Biotherapeutics (NWBT) Receives U.S. Patent on Broad Processes for Producing More Potent Dendritic Cells
3/18/2013
More...
|
Rosetta Genomics Ltd. (ROSG) Receives 25th U.S. Patent Allowance
3/18/2013
More...
|
Genetic Technologies Limited (GTG.AX) Provides U.S. Patent Re-Examination Update
3/15/2013
More...
|
Cryo-Cell International (CCEL) Affiliate Earns Patent for Processing Umbilical Cord Blood for Therapeutic Use in Treating Neurodegenerative Diseases and Spinal Cord and Brain Injuries
3/15/2013
More...
|
European Patent Office to Grant Patent for Macrocure's CureXcell®
3/14/2013
More...
|
NeoStem, Inc. Announces Intellectual Property Expansion in Cardiovascular Disease
3/13/2013
More...
|
Echo Therapeutics (ECTE) Granted U.S. Patent for Prelude® SkinPrep System
3/12/2013
More...
|
Cereplast Granted Patent for Biodegradable Nanopolymer Compositions
3/12/2013
More...
|
Allergy Therapeutics plc Granted U.S. Patent for Sublingual Administration of MPL Adjuvant and Vaccine Antigens
3/11/2013
More...
|
Immunotech Laboratories Announces Canadian Special Access Program Could Allow Legal Treatment of Company's Patented (IPF-ITV-1) AIDS-HIV Treatment
3/7/2013
More...
|
Valensa International, LLC Receives Five US Patent Approvals on GoEasy™ Gastrointestinal Health Formula
3/7/2013
More...
|
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/614,111 Related to Vascepa® and Planned ANCHOR Indication
3/7/2013
More...
|
Alchemia Granted Key U.S. Patent
3/6/2013
More...
|
United States Patent & Trademark Office Grants Pfizer Inc. (PFE) Reissue Patent for Celebrex® (celecoxib capsules)
3/5/2013
More...
|
PROLOR Biotech (PBTH) Receives Notice of Allowance for New U.S. Patent Covering Methods for Decreasing Body Fat With hGH-CTP
3/5/2013
More...
|
AstraZeneca PLC (AZN) Release: Australia Federal Court Holds CRESTOR Patents Invalid
3/5/2013
More...
|
India Rejects Bayer AG (BAY.F) Plea Against Cheap Cancer Drug
3/5/2013
More...
|
RetroSense Therapeutics Announces Notice of Allowance for New U.S. Patent Application Broadly Covering Optogenetic Approaches to Vision Restoration
3/5/2013
More...
|
Aphios Granted United States Patent for Zindol
3/4/2013
More...
|
ImmunoCellular Therapeutics, Ltd Announces Issuance of Key Patent for ICT-121 Cancer Vaccine
3/4/2013
More...
|
Arrowhead Research Corporation (ARWR) Receives Notice of Patent Allowance for New Protease Sensitive Masking Chemistry for DPC siRNA Delivery System
2/28/2013
More...
|
Medifocus Obtains New U.S. Patent Covering the Use of the Prolieve Thermodilation System for Drug Delivery
2/25/2013
More...
|
Parametric Sound Corporation Files U.S. Patent Application for Emitter Innovation
2/21/2013
More...
|
Additional Patent Granted in China for BioDiem Ltd. (BDM.AX)'s Antimicrobial
2/21/2013
More...
|
Neurovance Receives Notice of Allowance for Composition of Matter Patent and Initiates Clinical Trial of New SR Formulation of EB-1020
2/21/2013
More...
|
BioDtech, Inc. Issued New United States Patent
2/20/2013
More...
|
Zalicus Inc. (ZLCS) Granted Composition-of-Matter Patent for Z944
2/20/2013
More...
|
Osiris Therapeutics, Inc. (OSIR) Successfully Defends Key Stem Cell Patent Challenge
2/19/2013
More...
|
BioIndustry Association Release: New Patent Court Makes UK Natural European Home for Global Life Science Businesses
2/19/2013
More...
|
La Jolla Pharmaceutical Company (LJPC) Receives Additional Notice of Allowance for Patent Covering Modified Pectin Compositions
2/14/2013
More...
|
Eli Lilly and Company (LLY) Threatens to Leave Canada Over Patent Rulings
2/14/2013
More...
|
Bristol-Myers Squibb Company (BMY): Patent on $1.4 Billion Hepatitis-B Treatment Invalid; Teva Pharmaceutical Industries Limited (TEVA) to Benefit
2/13/2013
More...
|
Collegium Pharmaceutical, Inc. Announces Notice of Allowance for U.S. Patent Covering Oxycodone DETERx®, a Tamper-Resistant, Extended-Release Opioid Product
2/12/2013
More...
|
Ryogen LLC Receives Nine Human Gene Patents in 2012
2/12/2013
More...
|
CryoXtract™ Instruments Announces Patent Allowance for Frozen Sample Aliquotting Technology
2/12/2013
More...
|
Biotech Support Group Release: Use of Cleanascite™ in "Method and Pharmaceutical Composition for Treatment of Intestinal Disease"
2/12/2013
More...
|
MorphoSys AG Receives First Patent on Novel Antibody Platform Ylanthia in the U.S.
2/8/2013
More...
|
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice of Allowance From Chinese Patent Office for Treatment and Prevention of Heart Disease
2/8/2013
More...
|
U.S. Patents Issued for Akonni Biosystems' Novel Thermal Cycling Technology
2/7/2013
More...
|
Mystic Pharmaceuticals Receives U.S. Patent for Intranasal Delivery Technology for Pharmaceuticals and Biologics
2/7/2013
More...
|
Mesoblast Limited Release: Key Mesenchymal Precursor Cell Patents Granted in United States and China
2/7/2013
More...
|
Horizon Pharma, Inc. (HZNP) Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims Covering RAYOS® (Prednisone) Delayed-Release Tablets
2/6/2013
More...
|
Stellar Biotechnologies, Inc. Files Provisional Application for Patent for KLH Adjuvant Innovations
2/6/2013
More...
|
Horizon Pharma, Inc. (HZNP) Announces Receipt of Additional U.S. Patent Allowance for DUEXIS®
2/5/2013
More...
|
La Jolla Pharmaceutical Company (LJPC) Receives Notice of Allowance for Patent Covering Modified Pectin Compositions
2/5/2013
More...
|
T2 Biosystems Announces Patent Covering T2Hemostasis
2/5/2013
More...
|
KAHR Medical Granted U.S. Patent Approval for One of Its Lead Products in Development, KAHR-101
2/4/2013
More...
|
Immunotech Laboratories (IMMB) Patented "IPF" Technology A Serious Contender in the Race for HIV & Cancer Cures
2/4/2013
More...
|
AmpliPhi Biosciences (TGEN) Receives Notice of Allowance on Key Patent for its Bacteriophage Therapy to Treat Drug-Resistant Biofilm-based Infections
2/4/2013
More...
|
Amarin Corporation PLC (AMRN) Announces Notification of Additional U.S. Patent Allowance for U.S. Application 13/272,520 Based on ANCHOR Clinical Trial Results
2/1/2013
More...
|
US Patent Granted to RBC Life Sciences, Inc. for Supplement that Supports Cognitive Function
1/31/2013
More...
|
Amarin Corporation PLC (AMRN) Announces Notification of Two Additional Patent Allowances for U.S. Applications (13/458,496 and 13/349,157) Related to Vascepa® and FDA Approved MARINE Indication
1/31/2013
More...
|
BioChemics, Inc. Awarded Patent for Development of Bifunctional Synthetic Molecules – A Novel Drug Delivery And Efficacy Enhancement Technology
1/30/2013
More...
|
Targeted Medical Pharma Receives Notice of Issuance for Comprehensive Billing Patent
1/30/2013
More...
|
TetraLogic Pharmaceuticals Announces Decision to Grant Japanese Patent on Birinapant
1/29/2013
More...
|
Sulfagenix, Inc. Announces the Issuance of a Key Patent
1/29/2013
More...
|
Microbix Biosystems Inc. (MBXBF)'s LumiSort Patent Upheld in U.S.
1/25/2013
More...
|
Alitair Announces Issuance of Patent Covering its Safer Formulation of Benzonatate
1/24/2013
More...
|
Amarin Corporation PLC (AMRN) Announces First Notification of U.S. Patent Allowance Based on ANCHOR Clinical Trial Results
1/24/2013
More...
|
Neurocrine Biosciences, Inc. (NBIX) Announces Additional European and United States Patents Issued on Proprietary VMAT2 Inhibitor
1/24/2013
More...
|
Celladon Corporation Receives Notice of Allowance From United States Patent and Trademark Office
1/23/2013
More...
|
Watson Pharmaceuticals, Inc. (WPI) Confirms Opana® ER Patent Challenge
1/23/2013
More...
|
Anergis Obtains U.S. Patent for Lead Product AllerT
1/23/2013
More...
|
NeoStem, Inc. Announces Further Expansion of Intellectual Property Coverage
1/22/2013
More...
|
Sionix Corporation Receives Additional Patent Award, Extends Its Intellectual Property Leadership in Dissolved Air Flotation
1/22/2013
More...
|
Addex Therapeutics (ADXN.SW) Announces Issuance of a Broad U.S. Composition of Matter Patent for ADX71441
1/22/2013
More...
|
NeuroSigma, Inc. Announces Receipt of Notice of Allowance of U.S. Patent Application Related to External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Neuropsychiatric Disorders
1/22/2013
More...
|
IntelliCell BioSciences (SVFC) Receives Notice of Allowance for Its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"
1/22/2013
More...
|
Kiadis Pharma Granted U.S. Patent for its Blood Cancer Treatment ATIR™
1/22/2013
More...
|
Discovery Laboratories (DSCO) Receives New US Patent for Pulmonary Surfactant Formulations
1/17/2013
More...
|
Wound Healing and Inflammation Patent Issued to BioChemics, Inc.
1/17/2013
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Extension of FUSILEV® (levoleucovorin) for Injection Patent Until 2022
1/17/2013
More...
|
Biotage AB (BIOTa.ST) Success in Re-Examination Proceedings
1/16/2013
More...
|
Advanomics Corporation, the Parent Company of Sunshine Biopharma, Inc., Files a New Patent Application for Its Multidrug Resistance Adva-27a Anticancer Compound
1/15/2013
More...
|
Nuvilex's Subsidiary Files International Patent for All-Natural Flu Virus Treatment
1/15/2013
More...
|
PuraMed BioScience Receives Patent Allowance on Over-the-Counter Migraine Pain Reliever, LipiGesic®M
1/15/2013
More...
|
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/610,217 Related to Vascepa® and FDA Approved MARINE Indication
1/11/2013
More...
|
Immunomedics, Inc. (IMMU) Announces U.S. Patent for Hexavalent DOCK-AND-LOCK™ Complexes
1/8/2013
More...
|
BIND Biosciences, Inc. Granted Five U.S. Patents for its Medicinal Nanoengineering® Platform and Lead Drug Candidate, BIND-014
1/8/2013
More...
|
Cell Signaling Technology, Inc. Granted Patent for PCR Methods for Detection of a Subset of Treatable Non-Small Cell Lung Cancers
1/7/2013
More...
|
RedHill Biopharma Ltd. (RDHL) Announces Issuance of New U.S. Patent and Provides Update on RHB-104 for Treatment of Crohn's Disease
1/7/2013
More...
|
PROLOR Biotech (PBTH) Receives Notice of Allowance for New U.S. Patent Covering Broad Applications of its CTP Platform for Long Acting Therapeutic Proteins
1/7/2013
More...
|
Entia Biosciences Files Nutrigenomics Patent for Hair, Skin, and Nails
1/7/2013
More...
|
USPTO Grants Santaris Pharma A/S' Request for Inter-Partes Reexamination of Patent Licensed to Regulus Therapeutics, Inc.
1/7/2013
More...
|
Eli Lilly and Company (LLY) May Have a $15 Billion "Wild Card" Up Its Sleeve: Analysis
1/7/2013
More...
|
Auxogyn, Inc. Announces First European Patent for Eeva™ Test
1/3/2013
More...
|
22nd Century Group, Inc. Announces Allowance of U.S. Patent for MPO Nicotine Biosynthesis Gene
1/3/2013
More...
|
Alkermes plc (ALKS) Announces Notice of Allowance of Key U.S. Patent for Aripiprazole Lauroxil, a New Schizophrenia Drug Candidate
1/3/2013
More...
|
Immunovative Inc. Announces Issuance of a Key Patent in Japan
1/2/2013
More...
|
NuPathe Inc. (PATH) Announces Allowance of Additional U.S. Patent Application for Zecuity
1/2/2013
More...
|
Suven Life Sciences Ltd Secures 3 Product Patents for Their New Chemical Entities, Inc.'s in Eurasia & Canada
1/2/2013
More...
|
Immunomedics, Inc. (IMMU) Announces New Patent for Antibodies Targeting CD19
12/21/2012
More...
|
MonoSolRx LLC Acquires U.S. Patent for Multifunctional Single Layer Film Drug Delivery Technology
12/20/2012
More...
|
Pisgah Laboratories, Inc Receives Patent for Innovative Abuse-Deterrent Technology Targeting Pseudoephedrine and Ephedrine, Common Ingredients for Methamphetamine Production
12/20/2012
More...
|
Atlantic Pharmaceuticals, Inc. Announces Two Patent Issuances for Its Tamper-Resistant Pharmaceutical Platform
12/20/2012
More...
|
CutisPharma Inc. Announces Issuance of an Additional Patent for Suppository Compounding
12/19/2012
More...
|
European Patent Office Issues Its Intention to Grant Genervon Biopharmaceuticals a European Patent on Methods of Treating Neuronal Disorders Using MNTF Peptides and Analogs Thereof
12/18/2012
More...
|
Entia Biosciences Receives Canadian Patent Notice of Allowance for Use of Ergothioneine and Its Genetic Transporter
12/17/2012
More...
|
Aphios Granted United States Patent for Oral Delivery of Insulin
12/17/2012
More...
|
Rexahn Pharmaceuticals, Inc. Expands its Intellectual Property Around Class of Potent Anti-cancer Isoquinolinamine Compounds
12/17/2012
More...
|
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/623,450 Related to Vascepa® and FDA Approved MARINE Indication
12/13/2012
More...
|
Aegis Therapeutics, LLC Awarded Patent for Absorption-Enhancing Self-Assembling Thixotropic Aqueous Hydrogels
12/12/2012
More...
|
MediciNova, Inc. Receives Notice of Patent Allowance for Method of Treating Acute Exacerbations of Asthma
12/10/2012
More...
|
MorphoSys AG Strengthens Patent Position on anti-CD38 Cancer Program MOR202
12/6/2012
More...
|
Medgenics, Inc. Key Patent Claims Allowed in Japan Protecting Core Technology to be Used in Hepatitis Treatment
12/6/2012
More...
|
InTouch Health to Appeal Decision in Patent Suit
12/6/2012
More...
|
Lpath, Inc. Granted Key European Patent Related to iSONEP Drug Program
12/5/2012
More...
|
Allon Therapeutics, Inc. Release: the United States, New Zealand & Mexico Issue Patent for New Allon Platform
12/5/2012
More...
|
Skinvisible, Inc. (SKVI) Granted U.S. Patent for Topical Drug Delivery Technology
12/5/2012
More...
|
Takara Bio Grants Patent License to InVivoScribe Technologies, Inc. for FLT3-ITD Testing in Japan
12/5/2012
More...
|
Rainbow BioSciences, LLC Target Amarantus BioSciences, Inc. Wins MANF Patent Challenge in Europe
12/5/2012
More...
|
Jazz Pharmaceuticals plc (JAZZ) Announces Issuance of Additional Xyrem® Patent
12/5/2012
More...
|
Marina Biotech, Inc. Receives Key Patent Issuance From the USPTO for Its Unlocked Nucleobase Analog (UNA) Chemistry
12/4/2012
More...
|
Stellar Biotechnologies, Inc. Files U.S. Patent Application for KLH Manufacturing Innovations
12/4/2012
More...
|
Axiogenesis Earns U.S. Patent With In Vitro Drug Discovery Assay for Hypertrophic Cardiomyopathy
12/4/2012
More...
|
The Op-Ed: Johnson & Johnson (JNJ) Patent Move is "Inadequate"
11/30/2012
More...
|
Indian Board Rejects AstraZeneca PLC (AZN)'s Patent Plea on Cancer Drug
11/28/2012
More...
|
CureMark Announces New Patent Covering Treatment of Drug and Alcohol Addiction
11/28/2012
More...
|